Page 5 - P4304.1-V110 PSUK Mag June 2025

This promotional advert was created by Accord Healthcare Ltd and is intended for UK Healthcare Professionals.

Oxycodone hydrochloride Purchase profit impacts

Capsules in your dispensary

5mg, 10mg & 20mg
Over the past few weeks you will have seen in the press and the news a lot about
the new pharmacy contract that has been negotiated and whether this has been
good for pharmacy or not – but does this new contract impact dispensing practices
and if so how?

Whilst the pharmacy contract and pharmacy funding is separate to that of
dispensing doctors (differing claw back rates, fees for services such as pharmacy
first, different item fees etc.), there are some elements of funding that both
pharmacy and dispensing doctors share. The Drug Tariff is one of these areas, and
the amount of purchase profit that both pharmacy and dispensing practice are
allowed to generate from their purchasing through drug purchases is another.

So – how does the Drug Tariff and more importantly the profit generated from drugs
purchasing impact your dispensary….and what is changing with this new contract?
20mg
• First Generic Oxycodone immediate release capsules to be launched in the UK. NOW
• UK Manufacture. AVAILABLE How margin fits within dispensing

• Part of the Accord Scheme.
doctors funding

Product Presentation Anyone that has been to a PSUK study day recently will know that broadly there are
two main streams of funding into your dispensary.
Strength 5mg 10mg 20mg
Pack Size 56 56 56
A. Fees / remuneration for pharmaceutical services –
Product Format immediate release capsule immediate release capsule immediate release capsule which will include your dispensing fee and any other fee payments

Legal Category POM POM POM
B. Retained buying margin – or profit from the drugs you purchase.
Shelf Life 24 months 36 months 36 months
PIP Code 127-5619 127-5627 127-5734
Trade Price¹ £6.17 £12.35 £24.69 Retained buying margin is the difference between the price that a dispensing
practice pays for a medicine (after supplier discounts) and the price that the NHS
Drug Tariff Price - Cat C (March 25) £11.43 £22.86 £45.71 reimburses for the medicine (after discount deduction). Up until the recent changes
Profit per pack £5.26 £10.51 £21.02 to the contract, £800m annually is intended to be delivered through retained buying
margin. In the new contract, this number has now been uplifted to £900m meaning
1. Accord Proposition Price List April 2025 as an sector, there is £100m more purchase profit annually that can be realised –
which is good news.
Please click or scan the QR codes below to access the SmPC’s.
Before the introduction of a new contract in 2005, retained buying margin was
Oxycodone Capsules 5mg Oxycodone Capsules 10mg Oxycodone Capsules 20mg not a measured or protected income stream. In the early 2000’s the Government
was considering measures to restrict margin in the medicine supply chain. Options

Adverse events should be reported. included central procurement of medicines, or paying pharmacies and dispensing
Reporting forms and information can be practices only what they paid to purchase medicines.
found at https://yellowcard.mhra.gov.uk
There was widespread pushback against the Government. Community Pharmacy
Adverse events should also be reported to England (CPE then PSNC) argued that margin income was needed by both
Accord-UK LTD on 01271 385257 pharmacies and dispensing practices. Ultimately new arrangements were enacted
or email medinfo@accord-healthcare.com in 2005, which officially recognized margin, and therefore protected it as an income
stream. However, this protection came with the proviso that the margin must be
measured, and would be subject to calibration through the Drug Tariff.

Document Number: UK-Gen-Oxyc-01408
Date of Preparation: April 2025
Purchase Profit | PS Magazine 5

20/05/2025 15:38:24
P4304.1-V110 PSUK Mag June 2025.indd 5
P4304.1-V110 PSUK Mag June 2025.indd 5 20/05/2025 15:38:24